{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-26-000004","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.553816+00:00","generated_at":"2026-05-16T04:39:21.521243+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cardinal Health Q2 revenue $65.6B (+19%), non-GAAP EPS $2.63 (+36%), raises FY26 EPS outlook to $10.15-$10.35","bullets":["Revenue $65.6B (+19% YoY); GAAP diluted EPS $1.97 (+19%); non-GAAP diluted EPS $2.63 (+36%).","Pharma & Specialty profit $687M (+29%); Global Medical Products profit $37M (+106%); Other profit $179M (+52%).","FY2026 non-GAAP EPS guidance raised to $10.15-$10.35, representing 23%-26% growth.","Year-to-date share repurchases of $750M completed; reached targeted leverage range.","Acquired Solaris Health (urology MSO, >750 providers) on Nov 3; introduced ContinuCare Pathway program."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-26-000004","json":"https://secwatch.observer/filing/0000721371-26-000004.json","markdown":"https://secwatch.observer/filing/0000721371-26-000004.md","text":"https://secwatch.observer/filing/0000721371-26-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/0000721371-26-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/cah-20260205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:39:21.521243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}